Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter

Clinica Chimica Acta

Volumn 337, Issue 1-2, 2003, Pages 115-126

  Luo, Liu Ying ^a,b   Grass, Linda ^a   Diamandis, Eleftherios P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Human kallikrein; Serine proteases; Steroid hormone

Indexed keywords

ALDOSTERONE; ANDROGEN; ANDROSTANOLONE; DEXAMETHASONE; ESTRADIOL; ESTROGEN; FULVESTRANT; GESTAGEN; HORMONE RECEPTOR BLOCKING AGENT; KALLIKREIN; KALLIKREIN 10; MIFEPRISTONE; NORGESTREL; RU 56187; STEROID HORMONE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HORMONAL REGULATION; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION; SUPERNATANT; TRANSCRIPTION REGULATION; UPREGULATION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0142165032     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.07.008     Document Type: Article

References (44)

1. Yousef G.M., Diamandis E.P. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev. 22:2001;184-204.
2. Liu X.L., Wazer D.E., Watanabe K., Band V. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression. Cancer Res. 56:1996;3371-3379.
3. Luo L., Herbrick J.A., Scherer S.W., Beatty B., Squire J., Diamandis E.P. Structural characterization and mapping of the normal epithelial cell-specific 1 gene. Biochem. Biophys. Res. Commun. 247:1998;580-586.
4. Goyal J., Smith K.M., Cowan J.M., Wazer D.E., Lee S.W., Band V. The role for NES1 serine protease as a novel tumor suppressor. Cancer Res. 58:1998;4782-4786.
5. Luo L.Y., Rajpert-De Meyts E.R., Jung K., Diamandis E.P. Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue. Br. J. Cancer. 85:2001;220-224.
6. Luo L.Y., Grass L., Howarth D.J., Thibault P., Ong H., Diamandis E.P. Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues. Clin. Chem. 47:2001;237-246.
7. Riegman P.H., Vlietstra R.J., van der Korput H.A., Romijn J.C., Trapman J. Identification and androgen-regulated expression of two major human glandular kallikrein-1 (hGK-1) mRNA species. Mol. Cell. Endocrinol. 76:1991;181-190.
8. Magklara A., Grass L., Diamandis E.P. Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines. Breast Cancer Res. Treat. 59:2000;263-270.
9. Cleutjens K.B., van der Korput H.A., Ehren-van Eekelen C.C.et al. A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans. Mol. Endocrinol. 11:1997;1256-1265.
10. Clements J.A., Mukhtar A., Ehrlich A., Yap B. Kallikrein gene expression in the human uterus. Braz. J. Med. Biol. Res. 27:1994;1855-1863.
11. Aranda A., Pascual A. Nuclear hormone receptors and gene expression. Physiol. Rev. 81:2001;1269-1304.
12. Hollenberg S.M., Weinberger C., Ong E.S.et al. Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature. 318:1985;635-641.
13. Chang C.S., Kokontis J., Liao S.T. Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. Proc. Natl. Acad. Sci. U. S. A. 85:1988;7211-7215.
14. Gottlicher M., Heck S., Herrlich P. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J. Mol. Med. 76:1998;480-489.
15. Schuur E.R., Henderson G.A., Kmetec L.A., Miller J.D., Lamparski H.G., Henderson D.R. Prostate-specific antigen expression is regulated by an upstream enhancer. J. Biol. Chem. 271:1996;7043-7051.
16. Cleutjens K.B., van Eekelen C.C., van der Korput H.A., Brinkmann A.O., Trapman J. Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter. J. Biol. Chem. 271:1996;6379-6388.
17. Cleutjens K.B., van der Korput H.A., van Eekelen C.C., van Rooij H.C., Faber P.W., Trapman J. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol. Endocrinol. 11:1997;148-161.
18. Huang W., Shostak Y., Tarr P., Sawyers C., Carey M. Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer. J. Biol. Chem. 274:1999;25756-25768.
19. Murtha P., Tindall D.J., Young C.Y. Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5′ promoter region of the gene. Biochemistry. 32:1993;6459-6464.
20. Yu D.C., Sakamoto G.T., Henderson D.R. Identification of the transcriptional regulatory sequences of human kallikrein 2 and their use in the construction of calydon virus 764, an attenuated replication competent adenovirus for prostate cancer therapy. Cancer Res. 59:1999;1498-1504.
21. Mitchell S.H., Murtha P.E., Zhang S., Zhu W., Young C.Y. An androgen response element mediates LNCaP cell dependent androgen induction of the hK2 gene. Mol. Cell. Endocrinol. 168:2000;89-99.
22. Murray S.R., Chao J., Lin F.K., Chao L. Kallikrein multigene families and the regulation of their expression. J. Cardiovasc. Pharmacol. 15:1990;S7-S16.
23. Luo L.Y., Grass L., Diamandis E.P. The normal epithelial cell-specific 1 (NES1) gene is up-regulated by steroid hormones in the breast carcinoma cell line BT-474. Anticancer Res. 20:2000;981-986.
24. Luo L.Y., Katsaros D., Scorilas A.et al. The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis. Cancer Res. 63:2003;807-811.
25. Christopoulos T.K., Diamandis E.P. Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates. Anal. Chem. 64:1992;342-346.
26. Sathya G., Li W., Klinge C.M., Anolik J.H., Hilf R., Bambara R.A. Effects of multiple estrogen responsive elements, their spacing, and location on estrogen response of reporter genes. Mol. Endocrinol. 11:1997;1994-2003.
27. McKenna N.J., Lanz R.B., O'Malley B.W. Nuclear receptor coregulators: cellular and molecular biology. Endocr. Rev. 20:1999;321-344.
28. Collingwood T.N., Urnov F.D., Wolffe A.P. Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. J. Mol. Endocrinol. 23:1999;255-275.
29. Magklara A., Brown T.J., Diamandis E.P. Characterization of androgen receptor and nuclear receptor co-regulator expression in human breast cancer cell lines exhibiting differential regulation of kallikreins 2 and 3. Int. J. Cancer. 100:2002;507-514.
30. Li B., Goyal J., Dhar S.et al. CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression. Cancer Res. 61:2001;8014-8021.
31. Taplin M.E., Bubley G.J., Shuster T.D.et al. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N. Engl. J. Med. 332:1995;1393-1398.
32. Luo L.Y., Katsaros D., Scorilas A.et al. Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma. Clin. Cancer Res. 7:2001;2372-2379.
33. Risch H.A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J. Natl. Cancer Inst. 90:1998;1774-1786.
34. Clinton G.M., Hua W. Estrogen action in human ovarian cancer. Crit. Rev. Oncol. Hematol. 25:1997;1-9.
35. Luo L.Y., Diamandis E.P., Look M.P., Soosaipillai A.P., Foekens J.A. Higher expression of human kallikrein 10 in breast cancer tissues predicts tamoxifen resistance. Br. J. Cancer. 86:2002;1790-1796.
36. Li Q., Harju S., Peterson K.R. Locus control regions: coming of age at a decade plus. Trends Genet. 15:1999;403-408.
37. Engel J.D., Tanimoto K. Looping, linking, and chromatin activity: new insights into beta-globin locus regulation. Cell. 100:2000;499-502.
38. Southard-Smith M., Pierce J.C., MacDonald R.J. Physical mapping of the rat tissue kallikrein family in two gene clusters by analysis of P1 bacteriophage clones. Genomics. 22:1994;404-417.
39. Geisinger K.R., Kute T.E., Pettenati M.J.et al. Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors. Cancer. 63:1989;280-288.
40. Galtier-Dereure F., Capony F., Maudelonde T., Rochefort H. Estradiol stimulates cell growth and secretion of procathepsin D and a 120-kilodalton protein in the human ovarian cancer cell line BG-1. J. Clin. Endocrinol. Metab. 75:1992;1497-1502.
41. Baldwin W.S., Curtis S.W., Cauthen C.A., Risinger J.I., Korach K.S., Barrett J.C. BG-1 ovarian cell line: an alternative model for examining estrogen-dependent growth in vitro. In Vitro Cell. Dev. Biol. Anim. 34:1998;649-654.
42. Jones J., Lagasse L.D., Karlan B.Y. Steroid hormonal independence of HER-2/neu mRNA expression in four human ovarian carcinoma cell lines. Gynecol. Oncol. 55:1994;421-426.
43. Hamilton T.C., Young R.C., McKoy W.M., Grotzinger K.R., Green J.A., Chu E.W.et al. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res. 43:1983;5379-5389.
44. Horoszewicz J.S., Leong S.S., Kawinski E.et al. LNCaP model of human prostatic carcinoma. Cancer Res. 43:1983;1809-1818.